RESEARCH AND DIAGNOSTIC SYSTEMS, INC

Research and Diagnostic Systems, Inc. specializes in the development, manufacturing, and supply of high-purity biological reagents, recombinant proteins, and proprietary assay components for biomedical research and diagnostic applications. The company’s core expertise lies in the production of custom-purified proteins, fetal bovine serum, multiplexed bead-based reagents, and specialized cell culture media, serving as a critical supplier of raw materials for life science laboratories. Their technical capabilities include protein expression and purification, antibody conjugation, and assay development for in vitro diagnostics, with demonstrated experience in supporting complex research workflows requiring stringent quality control and batch consistency. A key differentiator is their ability to deliver custom, non-commercial biological products under controlled manufacturing conditions, enabling niche research applications that standard catalog items cannot satisfy. The contractor maintains a consistent and deep relationship with the Department of Health and Human Services, providing essential biological supplies and laboratory reagents to its research arms, including the National Institutes of Health and its institutes such as NICHD. Their work supports fundamental biomedical research, vaccine development, and diagnostic innovation, often involving proprietary or low-volume materials not available through commercial channels. Industry focus centers on biological product manufacturing (NAICS 325414), with complementary capabilities in in-vitro diagnostic substance manufacturing (325413) and analytical instrument supply (334516). This positions them as a specialized vendor within the life sciences supply chain, serving government-funded research and translational medicine initiatives that require bespoke biological materials. As a small business structured as a 2L entity based in Minneapolis, Minnesota, the company operates without federal certifications but maintains a focused presence in the federal biomedical procurement market, delivering mission-critical materials to high-regulation research environments.